Compound

D0484 | ritolukast

Molecular Formula C17H13F3N2O3S
Molecular Weight 382.4
Structure

Toxicity Dose Time Species Model Method Action Positive criterion Reference
UNCOUPLING rat isolated liver mitochondria measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay increase 53


  • 0E8R4GDE2Q 1,1,1-Trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide 1,1,1-trifluoro-N-[3-(quinolin-2-ylmethoxy)phenyl]methanesulfonamide
    111974-60-8 AKOS000278710 BDBM50006806
    C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide( Wy-48,252) C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide(Wy 48252)
    C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide(Wy-48,252); CHEMBL17344 D02849
    DTXSID90149795 GOHUJGMYCZDYDF-UHFFFAOYSA-N Methanesulfonamide, 1,1,1-trifluoro-N-(3-(2-quinolinylmethoxy)phenyl)-
    N-[3-[(2-Quinolinyl)methoxy]phenyl]trifluoromethane sulfonamide Q27236668 RITOLUKAST
    Ritolukast (USAN/INN) Ritolukast [USAN:INN] Ritolukastum
    Ritolukastum [INN-Latin] SCHEMBL38043 UNII-0E8R4GDE2Q
    Wy 48252 Wy-48252

    CAS Number 111974-60-8
    PubChem Compound 60539
    KEGG Drug D02849